Misdiagnosis of Systemic Lupus Erythematosus Combined with Urinary Tuberculosis Leading to Tuberculous Meningitis: A Case Report and Literature Review
Honglei Ma,Yuqun Wang,Junhong Liu,Linping Du,Xiaodong Wang,Yingliang Wang
DOI: https://doi.org/10.2147/IDR.S420833
2023-07-19
Infection and Drug Resistance
Abstract:Honglei Ma, 1 Yuqun Wang, 1 Junhong Liu, 1 Linping Du, 1 Xiaodong Wang, 2 Yingliang Wang 2 1 Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, Shandong Province, People's Republic of China; 2 Rheumatology and Immunology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, People's Republic of China Correspondence: Yingliang Wang, Affiliated Hospital of Weifang University, No. 2428, Yuhe Road, Kuiwen District, Weifang, Shandong Province, People's Republic of China, Tel +86 13869663571, Fax +86 5363081201, Email Purpose: To explore the lessons learned from the misdiagnosis of systemic lupus erythematosus (SLE) combined with urinary tuberculosis leading to tuberculous meningitis (TBM) and the diagnosis and treatment of TBM through case reports and review of the literature. Methods: We report a case of an SLE patient presenting with urinary tuberculosis infection misdiagnosed as interstitial cystitis and complex urinary tract infection, who developed neurological infection after a cystocentesis biopsy and was eventually diagnosed with TBM. In addition, all cases of SLE combined with TBM from January 1975 to February 2022 were summarised and reviewed to compare current diagnostic and treatment strategies for the disease. Results: The patient suddenly developed neurological symptoms after cystocentesis biopsy, and we detected Mycobacterium tuberculosis in the macrogenomic next-generation sequence (mNGS) of the cerebrospinal fluid. We therefore excluded interstitial cystitis and neuropsychiatric lupus to confirm the diagnosis of Mycobacterium tuberculosis infection leading to urinary tract tuberculosis and TBM. Conclusion: SLE is complicated by urological tuberculosis, surgery triggering hematogenous dissemination leading to tuberculous meningitis. At the same time, the lack of specificity in the clinical presentation of patients makes it easy to misdiagnose neuropsychiatric lupus and delay treatment, so timely and accurate diagnosis and effective anti-tuberculosis treatment are essential. Keywords: tuberculosis, meningeal, urinary tuberculosis, lupus erythematosus, systemic, lupus vasculitis, central nervous system SLE is a multi-organ system autoimmune disease that produces a variety of pathogenic autoantibodies and immune complexes. In patients with SLE, 30–50% of morbidity and mortality is attributed to infections, mainly of the respiratory and urinary tract, skin and soft tissues, and blood, while central nervous system infections account for only 3% of all cases of infection. Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis and is one of the leading causes of global ill health and one of the leading causes of death. It is estimated that around a quarter of the world's population is already infected with TB, and the World Health Organization estimates that the number of new TB diagnoses will rise again to 6.4 million in 2021. 1 Central nervous system tuberculosis occurs in about 1% of all patients with active tuberculosis and immunosuppressed adults are more susceptible to disseminated disease and involvement of the central nervous system. 2 TBM is the most common form of central nervous system tuberculosis and the most severe form of TB, with 1 in 5 TBM cases resulting in death. 3,4 TBM is difficult to distinguish from other causes of meningoencephalitis and the prognosis is generally poor once the neurological symptoms of advanced disease (such as coma, seizures, increased intracranial pressure, and hemiparesis) are present. The exact mechanism of SLE combined with TBM is unknown and may be related to immune abnormalities associated with SLE, such as immunoglobulin deficiency, complement deficiency, and reduced complement receptor expression, combined with immunosuppression, and hormone induced cellular immune deficiency, leading to an increased chance of pathogenic infection and death. Because SLE is susceptible to Mycobacterium tuberculosis infection, it has been suggested that isoniazid (INH) may be used in combination with primary therapy to prevent tuberculosis. However, the effectiveness of INH in preventing the development of TB in this group of patients is not known. The balance between SLE and TB treatment after infection with Mycobacterium tuberculosis is also a major challenge. There are still very limited reports of cases of TBM following surgery for SLE combined with urological TB. Here, we provide a case report as a reference and a summary of the available reports on this disease to explore the early diagnosis, treatment strategies, and future directions of e -Abstract Truncated-
pharmacology & pharmacy,infectious diseases